<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T18:41:29Z</responseDate>
  <request identifier="oai:figshare.com:article/34014054" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34014054</identifier>
        <datestamp>2026-09-28T12:54:28Z</datestamp>
        <setSpec>category_374</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Table 1_Daily consumption of Fuzhuan brick tea improves lipid profile and vascular function associated with modulation in gut microbiota composition in healthy adults: a pilot randomized controlled trial.docx</dc:title>
          <dc:creator>Fuqiang Liu (451879)</dc:creator>
          <dc:creator>Ying Lv (1490539)</dc:creator>
          <dc:creator>Ting Wang (16292)</dc:creator>
          <dc:creator>Chune Li (13774891)</dc:creator>
          <dc:creator>Yudan Zhang (7847699)</dc:creator>
          <dc:creator>Lin Liu (74495)</dc:creator>
          <dc:creator>Xin Hu (38924)</dc:creator>
          <dc:creator>Yan Liang (139654)</dc:creator>
          <dc:creator>Feng Zhu (685)</dc:creator>
          <dc:creator>Junkui Wang (813942)</dc:creator>
          <dc:subject>Clinical and Sports Nutrition</dc:subject>
          <dc:subject>flow-mediated dilation</dc:subject>
          <dc:subject>Fuzhuan brick tea</dc:subject>
          <dc:subject>gut microbiota</dc:subject>
          <dc:subject>lipid profile</dc:subject>
          <dc:subject>nitroglycerin-mediated dilation</dc:subject>
          <dc:subject>vascular function</dc:subject>
          <dc:description>Background&lt;p&gt;Dietary strategies play a pivotal role in the prevention of cardiometabolic diseases. Animal studies have shown that Fuzhuan brick tea (FBT), a popular post-fermented tea, enhances cardiometabolic health by modulating the gut microbiota; however, there is no definitive evidence from human trials. This 12-week randomized controlled trial investigated the effects of FBT on the lipid profile, vascular function, and gut microbiota in healthy adults.&lt;/p&gt;Methods&lt;p&gt;This 12-week, open-label, parallel-group, randomized controlled trial was conducted in a rural community in northern China from September to November 2021. After giving informed consent, 120 healthy adults recruited were randomly assigned to either a group consuming two daily glasses of brewed FBT infusion (totaling 12 g/day) or a group consuming an equivalent amount of water. Serum lipid levels and vascular function, as indicated by flow-mediated dilation and nitroglycerin-mediated dilation, were measured at baseline (0 weeks) and 12 weeks after intervention. Fecal samples collected at baseline, 6 weeks, and 12 weeks underwent profiling of microbiota composition by shotgun metagenomic sequencing. This trial was completed and registered at chictr.org.cn (registration number ChiCTR2100047294).&lt;/p&gt;Results&lt;p&gt;Compared to water, consumption of FBT resulted in significantly reduced low-density lipoprotein cholesterol levels, with improved vascular function (the co-primary outcomes). The longitudinal metagenomic analysis detected no significant alterations in richness and distribution (alpha diversity). However, a subtle but statistically detectable shift in the gut microbiota composition (beta diversity) was observed. Exploratory species-level analyses suggested increases in bacteria that produce short-chain fatty acids, such as Roseburia hominis, Eubacterium saphenum, Eubacterium sp. AF15 50, Alistipes dispar, Blautia stercoris, and Lactobacillus amylolyticus, which were correlated with the lipid profile or vascular function.&lt;/p&gt;Conclusion&lt;p&gt;Daily consumption of FBT demonstrated beneficial effects on lipid levels and vascular function in healthy adults, and was associated with exploratory shifts in gut microbiota composition, supporting FBT consumption is a simple, affordable, and practical dietary strategy for improving cardiometabolic health.&lt;/p&gt;Clinical trial registration&lt;p&gt;http://www.chictr.org.cn/, identifier ChiCTR2100047294.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-28T12:54:28Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fnut.2026.1827773.s009</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Table_1_Daily_consumption_of_Fuzhuan_brick_tea_improves_lipid_profile_and_vascular_function_associated_with_modulation_in_gut_microbiota_composition_in_healthy_adults_a_pilot_randomized_controlled_trial_docx/34014054</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
